The investigational drug darolutamide can help delay the spread of prostate cancer in some men with the disease, a recent clinical trial shows. In addition, the drug caused fewer side effects than similar prostate cancer drugs.
from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/2JcfSPF